已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Prognosis of lung cancer associated with cystic airspaces: A propensity score matching analysis

医学 肺癌 内科学 匹配(统计) 倾向得分匹配 癌症 病理 肿瘤科
作者
Yingran Shen,Yunfei Zhang,Yanhua Guo,Weitong Li,Yan Huang,Tong Wu,Gening Jiang,Jie Dai
出处
期刊:Lung Cancer [Elsevier]
卷期号:159: 111-116 被引量:23
标识
DOI:10.1016/j.lungcan.2021.07.003
摘要

The association between the morphological characteristics and survival outcome of lung cancer associated with cystic airspaces (LCCAs) is unclear due to rarity of this disease. The current study attempted to compare the survival outcome between LCCAs and non-LCCAs and investigate the correlation between imaging features and prognosis of LCCA.Of 10,835 patients diagnosed with non-small cell lung carcinoma (NSCLC) between January 2015 and December 2016, 123 patients with LCCA were included. The non-LCCA group comprised 3136 patients with primary solitary adenocarcinoma or squamous cell lung cancer. Propensity score matching (PSM) was performed for age, sex, tumor size, tumor stage, and lymph node involvement in a 1:1 ratio between the LCCAs and non-LCCAs, and the correlation between radiological features and recurrence-free survival (RFS) was analyzed.The computed tomography (CT) lesion size was found to be higher in all LCCA subtypes, particularly in Type III (a cystic airspace with a mural nodule) and Type IV (mixed) LCCAs (3.09 and 3.65 cm, respectively), than in non-LCCAs (2 cm) after PSM. Three-year RFS in the LCCA group was higher than in the non-LCCA group (Type I- IV LCCAs: 100%, 84%, 77% and 83%, respectively vs. non-LCCAs: 77%). However, statistically significant difference was only found in comparison between LCCA Type I (thin-walled) and non-LCCA groups (P = 0.026). Type III lung cancer exhibited the worst survival among all four LCCA subtypes.The CT lesion size and pathologic tumor size varied significantly across LCCAs. Type I LCCAs exhibited better survival than non-LCCAs, whereas Type III LCCAs exhibited the worst survival rate among the four LCCA subtypes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
蛋黄派关注了科研通微信公众号
3秒前
鲍惜寒发布了新的文献求助10
3秒前
雪生在无人荒野完成签到,获得积分10
4秒前
鲍惜寒完成签到 ,获得积分10
4秒前
829302yft完成签到,获得积分10
6秒前
醒醒发布了新的文献求助10
6秒前
6秒前
111发布了新的文献求助10
7秒前
bkagyin应助晚上吃什么采纳,获得10
7秒前
科研通AI2S应助淡淡从安采纳,获得10
8秒前
9秒前
HJJHJH发布了新的文献求助10
10秒前
10秒前
10秒前
12秒前
逐风发布了新的文献求助10
13秒前
14秒前
14秒前
冰冰爱干饭给冰冰爱干饭的求助进行了留言
14秒前
hbkj发布了新的文献求助10
15秒前
16秒前
安静如冰完成签到,获得积分20
17秒前
18秒前
19秒前
19秒前
20秒前
20秒前
友好寄柔发布了新的文献求助30
21秒前
慕青应助二碘化钾采纳,获得30
21秒前
绝不延毕完成签到 ,获得积分10
21秒前
22秒前
wzzznh发布了新的文献求助10
23秒前
23秒前
傲娇小废柴完成签到,获得积分20
26秒前
五指袜发布了新的文献求助10
26秒前
27秒前
无花果应助zhouleiwang采纳,获得10
27秒前
张张发布了新的文献求助10
29秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6020391
求助须知:如何正确求助?哪些是违规求助? 7618972
关于积分的说明 16164789
捐赠科研通 5168113
什么是DOI,文献DOI怎么找? 2765923
邀请新用户注册赠送积分活动 1747978
关于科研通互助平台的介绍 1635898